Andrew D. Jones - Net Worth and Insider Trading

Andrew D. Jones Net Worth

The estimated net worth of Andrew D. Jones is at least $72 dollars as of 2024-11-10. Andrew D. Jones is the CFO of NovaBay Pharmaceuticals Inc and owns about 104 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $72. Details can be seen in Andrew D. Jones's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew D. Jones has not made any transactions after 2021-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew D. Jones

To

Andrew D. Jones Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew D. Jones owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Andrew D. Jones’s form 4 insider trades.

Insider Ownership Summary of Andrew D. Jones

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2021-12-06 CFO and Treasurer

Andrew D. Jones Latest Holdings Summary

Andrew D. Jones currently owns a total of 1 stock. Andrew D. Jones owns 104 shares of NovaBay Pharmaceuticals Inc (NBY) as of December 6, 2021, with a value of $72.

Latest Holdings of Andrew D. Jones

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2021-12-06 104 0.69 72

Holding Weightings of Andrew D. Jones


Andrew D. Jones Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew D. Jones has made a total of 1 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 37 shares on December 6, 2021, which cost Andrew D. Jones around $20,000.

Insider Trading History of Andrew D. Jones

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew D. Jones Trading Performance

GuruFocus tracks the stock performance after each of Andrew D. Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D. Jones is -31.74%. GuruFocus also compares Andrew D. Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D. Jones within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew D. Jones's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew D. Jones

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.14 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew D. Jones Ownership Network

Ownership Network List of Andrew D. Jones

No Data

Ownership Network Relation of Andrew D. Jones

Insider Network Chart

Andrew D. Jones Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Andrew D. Jones is the CFO and Treasurer of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Andrew D. Jones Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew D. Jones. You might contact Andrew D. Jones via mailing address: 2000 Powell Street, Suite 1150, Emeryville Ca 94608.